« Challenges And Changes in Vaccine Manufacture | Main | GSK and Actelion Do Not Have the Perfect Sleeper »

01/28/2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0148c81cdb3c970c

Listed below are links to weblogs that reference Sanofi PARP Inhibitor Fails Phase III Breast Cancer Trial:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

More of this from In the Pipeline including an update of competition in this area (PARP1)
http://pipeline.corante.com/archives/2011/01/31/sanofis_parp1_inhibitor_misses.php

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada